July 12, 2017
A Delaware federal judge ruled Tuesday that Par Pharmaceutical Inc.'s new drug application for a generic version of Ferring Pharmaceuticals Inc.'s colonoscopy treatment Prepopik infringed Ferring’s patents, weighing Ferring’s expert testimony over that of Par.